Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 20, 16:00
618.50
1.35 (0.22%)
VOLUME 66,516
LIVE
NSE
Apr 20, 15:58
618.60
0.8 (0.13%)
VOLUME 1,470,307
News on Aurobindo Pharma
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma Q4 PAT seen up 10.7% YoY to Rs. 570 cr: HDFC Securities

1.01 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 13.8 percent Y-o-Y (down 5.5 percent Q-o-Q) to Rs. 4,100 crore, according to HDFC Securities....

Buy Aurobindo Pharma, target Rs 792: SMC Global Securities

11.57 am | 19 Apr 2018 |  Source: Moneycontrol.com

"The stock will see a target price of Rs 792 in 8-10 months timeframe on a one-year average P/E of 16.77x and FY19 (E) earnings of Rs 47.20," says a r...

Aurobindo Q4 PAT seen up 25.3% YoY to Rs. 648.2 cr: Edelweiss

5.55 pm | 16 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 19 percent Y-o-Y to Rs. 4,334.4 crore, according to Edelweiss....

Buy Aurobindo Pharma, target Rs 680: Achin Goel

10.54 am | 12 Apr 2018 |  Source: Moneycontrol.com

"Traders can accumulate the stock in the range of Rs 612-618 for the target of Rs 680 and a stop loss below Rs 587," says Achin Goel, Head of Wealth M...

Accumulate Aurobindo Pharma; target of Rs 728: Arihant Capital

8.01 pm | 11 Apr 2018 |  Source: Moneycontrol.com

Arihant Capital recommended accumulate rating on Aurobindo Pharma with a target price of Rs 728 in its research report dated April 10, 2018....

Top 10 stocks handpicked by experts to buy in FY19 which can give up to 40% return

10.00 am | 02 Apr 2018 |  Source: Moneycontrol.com

FY19 promises to be a volatile year for equity markets with indices moving 10-20% in either direction. There are plenty of global headwinds which migh...

Here are top 4 stocks ideal for wealth creation for next 2-3 years

10.30 am | 01 Apr 2018 |  Source: Moneycontrol.com

Nifty’s inability to cross key levels like 10500-10600 zones confirms the view of advantage bears from a medium-term perspective, says JK Jain, hea...

Stocks in the news: JP Associates, Aurobindo Pharma, Dilip Buildcon, Infosys, Gravita 

7.43 am | 16 Mar 2018 |  Source: Moneycontrol.com

JP Associates | Ujjivan | Mindtree | Jaypee Infra | SpiceJet | Infosys | HDFC Bank | Gravita | Wipro and Aegis Logistics are the stocks which ...

Aurobindo Pharma falls 2% after USFDA finds female mosquito in unit 4

3.27 pm | 12 Mar 2018 |  Source: Moneycontrol.com

US Food and Drug Administration officials found a 'large female mosquito' in a facility of Aurobindo Pharma during inspection, which, accordin...

Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

4.40 pm | 09 Feb 2018 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated ...

Aurobindo Pharma may post 18% growth in Q3 profit, US business seen up 12%

12.28 pm | 07 Feb 2018 |  Source: CNBC-TV18

Europe and Rest of World sales are likely to grow 15-18 percent YoY while API business is likely to be flat....

Buy Aurobindo Pharma; target of Rs 904: Khambatta Securities

3.45 pm | 23 Nov 2017 |  Source: Moneycontrol.com

Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 904 in its research report dated...

Buy Aurobindo Pharma; target of Rs 1030: Centrum

4.56 pm | 22 Nov 2017 |  Source: Moneycontrol.com

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 10...

Aurobindo Pharma Q2 net up 29% at Rs 780.97 cr 

8.50 am | 10 Nov 2017 |  Source: PTI

The company had posted a net profit of Rs 605.55 crore for the corresponding period of the previous fiscal, Aurobindo Pharma said in a BSE filing....

Aurobindo Pharma Q2 profit seen up 15% to Rs 696 cr, operating margin may grow 110 bps 

5.26 pm | 08 Nov 2017 |  Source: CNBC-TV18

EBITDA (earnings before interest, tax, depreciation and amortisation) may increase 15.6 percent year-on-year to Rs 1,074.4 crore and margin may expand...

1 2 3
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.